The Angelman Syndrome Protein Ube3a Is Required for Polarized Dendrite Morphogenesis in Pyramidal Neurons

被引:77
|
作者
Miao, Sheng [1 ,2 ]
Chen, Renchao [1 ,2 ]
Ye, Jiahao [1 ,2 ]
Tan, Guo-He [1 ,2 ]
Li, Shuai [1 ,2 ]
Zhang, Jing [1 ,2 ]
Jiang, Yong-hui [3 ]
Xiong, Zhi-Qi [1 ,2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China
[3] Duke Univ, Div Med Genet, Dept Pediat, Sch Med, Durham, NC 27710 USA
来源
JOURNAL OF NEUROSCIENCE | 2013年 / 33卷 / 01期
基金
中国国家自然科学基金;
关键词
UBIQUITIN LIGASE; E6-ASSOCIATED PROTEIN; CEREBRAL-CORTEX; GENE-TRANSFER; MIGRATION; SYNAPSE; ELECTROPORATION; DEGRADATION; ORIENTATION; NEOCORTEX;
D O I
10.1523/JNEUROSCI.2509-12.2013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pyramidal neurons have a highly polarized dendritic morphology, characterized by one long apical dendrite and multiple short basal dendrites. They function as the primary excitatory cells of the mammalian prefrontal cortex and the corticospinal tract. However, the molecular mechanisms underlying the development of polarized dendrite morphology in pyramidal neurons remain poorly understood. Here, we report that the Angelman syndrome (AS) protein ubiquitin-protein ligase E3A (Ube3a) plays an important role in specifying the polarization of pyramidal neuron dendritic arbors in mice. shRNA-mediated downregulation of Ube3a selectively inhibited apical dendrite outgrowth and resulted in impaired dendrite polarity, which could be rescued by coexpressing mouse Ube3a isoform 2, but not isoform 1 or 3. Ube3a knockdown also disrupted the polarized distribution of the Golgi apparatus, a well established cellular mechanism for asymmetric dendritic growth in pyramidal neurons. Furthermore, downregulation of Ube3a completely blocked Reelin-induced rapid deployment of Golgi into dendrite. Consistently, we also observed selective inhibition of apical dendrite outgrowth in pyramidal neurons in a mouse model of AS. Overall, these results show that Ube3a is required for the specification of the apical dendrites and dendrite polarization in pyramidal neurons, and suggest a novel pathological mechanism for AS.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 50 条
  • [41] Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families
    Nurmi, EL
    Bradford, Y
    Chen, YH
    Hall, J
    Arnone, B
    Gardiner, MB
    Hutcheson, HB
    Gilbert, JR
    Pericak-Vance, MA
    Copeland-Yates, SA
    Michaelis, RC
    Wassink, TH
    Santangelo, SL
    Sheffield, VC
    Piven, J
    Folstein, SE
    Haines, JL
    Sutcliffe, JS
    GENOMICS, 2001, 77 (1-2) : 105 - 113
  • [42] UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome
    Elgersma, Ype
    Sonzogni, Monica
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2021, 63 (07): : 802 - 807
  • [43] Gene therapy "unsilences" paternal Ube3a in Angelman syndrome model
    Dengler, V. L.
    GENETICS IN MEDICINE, 2021, 23 (03) : 428 - 428
  • [44] Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A
    Nenninger, Austin W.
    Willman, Matthew
    Willman, Jonathan
    Stewart, Emma
    Mesidor, Philippe
    Novoa, Michelle
    Morrill, Nicole K.
    Alvarez, Luis
    Joly-Amado, Aurelie
    Peters, Melinda M.
    Gulick, Danielle
    Nash, Kevin R.
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1329 - 1339
  • [45] Correction: Corrigendum: Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
    Jana Stanurova
    Anika Neureiter
    Michaela Hiber
    Hannah de Oliveira Kessler
    Kristin Stolp
    Roman Goetzke
    Diana Klein
    Agnes Bankfalvi
    Hannes Klump
    Laura Steenpass
    Scientific Reports, 8
  • [46] Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome
    Gustin, Richard M.
    Bichell, Terry Jo
    Bubser, Michael
    Daily, Jennifer
    Filonova, Irina
    Mrelashvili, Davit
    Deutch, Ariel Y.
    Colbran, Roger J.
    Weeber, Edwin J.
    Haas, Kevin F.
    NEUROBIOLOGY OF DISEASE, 2010, 39 (03) : 283 - 291
  • [47] UBE3A/E6-AP mutations cause Angelman syndrome
    Tatsuya Kishino
    Marc Lalande
    Joseph Wagstaff
    Nature Genetics, 1997, 15 : 70 - 73
  • [48] SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome
    Runte, M
    Kroisel, PM
    Gillessen-Kaesbach, G
    Varon, R
    Horn, D
    Cohen, MY
    Wagstaff, J
    Horsthemke, B
    Buiting, K
    HUMAN GENETICS, 2004, 114 (06) : 553 - 561
  • [49] Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS
    Hitchins, MP
    Rickard, S
    Dhalla, F
    de Vries, BBA
    Winter, R
    Pembrey, ME
    Malcolm, S
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 125A (02) : 167 - 172
  • [50] UBE3A "mutations" in two unrelated and phenotypically different Angelman syndrome patients
    Fung, DCY
    Yu, B
    Cheong, KF
    Smith, A
    Trent, RJ
    HUMAN GENETICS, 1998, 102 (04) : 487 - 492